CRH Medical Stock Price, News & Analysis (NYSEAMERICAN:CRHM)

$1.80 -0.10 (-5.26 %)
(As of 11/22/2017 09:34 AM ET)
Previous Close$1.90
Today's Range$1.75 - $1.90
52-Week Range$1.46 - $9.25
Volume21,100 shs
Average Volume154,677 shs
Market Capitalization$140.84 million
P/E RatioN/A
Dividend YieldN/A
Beta1.47

About CRH Medical (NYSEAMERICAN:CRHM)

CRH Medical logoCRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology. The Company's product distribution strategy focuses on physician education, patient outcomes, and patient awareness. The Company's CRH O'Regan System, platform that provides gastrointestinal is a single use, disposable, hemorrhoid banding technology for treating hemorrhoid grades I-IV. The Company distributes the CRH O'Regan System, treatment protocols, operational and marketing expertise as a package to physicians. The Company's subsidiary, Gastroenterology Anesthesia Associates, LLC, provides anesthesiology services for gastroenterology procedures.


Industry, Sector and Symbol:
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Sector: N/A
  • Symbol: NYSEAMERICAN:CRHM
  • Previous Symbol: NYSEARCA:CRHM
  • CUSIP: N/A
  • Web: investors.crhsystem.com
Misc:
  • Outstanding Shares: 74,130,000
 

Frequently Asked Questions for CRH Medical (NYSEAMERICAN:CRHM)

What is CRH Medical's stock symbol?

CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."

How were CRH Medical's earnings last quarter?

CRH Medical Co. (NYSEAMERICAN:CRHM) released its quarterly earnings results on Wednesday, February, 22nd. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.01. The firm had revenue of $25.82 million for the quarter, compared to the consensus estimate of $23.30 million. View CRH Medical's Earnings History.

When will CRH Medical make its next earnings announcement?

CRH Medical is scheduled to release their next quarterly earnings announcement on Wednesday, February, 28th 2018. View Earnings Estimates for CRH Medical.

Where is CRH Medical's stock going? Where will CRH Medical's stock price be in 2017?

9 analysts have issued 12-month price objectives for CRH Medical's stock. Their predictions range from $5.00 to $10.00. On average, they expect CRH Medical's share price to reach $7.83 in the next twelve months. View Analyst Ratings for CRH Medical.

What are Wall Street analysts saying about CRH Medical stock?

Here are some recent quotes from research analysts about CRH Medical stock:

  • 1. According to Zacks Investment Research, "CRH Medical Corporation offers products and services to physicians for the treatment of gastrointestinal diseases primarily in the United States. The company provides the CRH O'Regan System, a single use, disposable and hemorrhoid banding technology for treating hemorrhoid grades I - IV. It distributes the CRH O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians. The company utilizes Web-based platform to connect doctors with patients as well as educating its install base of physicians. It also offers anesthesia services. CRH Medical Corporation is headquartered in Vancouver, Canada. " (11/14/2017)
  • 2. Cantor Fitzgerald analysts commented, "We are boosting our price target to $10 from $8 and reiterating our Overweight rating as we become more confident on CRHM's future. While other rollups have stumbled lately, CRHM is continuing, in measured ways, to make acquisitions and integrate them. Recent conversations with management have increased our confidence in their pipeline and the ripple effect that their deals create in the GI community. We continue to like the physician services business and believe that increasing numbers of gastroenterology practices will outsource anesthesia services in order to focus on clinical outcomes, improve operating efficiency and strengthen financial performance." (3/27/2017)

Are investors shorting CRH Medical?

CRH Medical saw a increase in short interest in October. As of October 31st, there was short interest totalling 1,331,365 shares, an increase of 11.0% from the October 13th total of 1,198,901 shares. Based on an average trading volume of 93,628 shares, the short-interest ratio is currently 14.2 days. Currently, 1.9% of the shares of the stock are sold short.

Who are some of CRH Medical's key competitors?

Who are CRH Medical's key executives?

CRH Medical's management team includes the folowing people:

  • Anthony F. Holler M.D., Independent Chairman of the Board (Age 63)
  • Edward J. Wright, Chief Executive Officer, Director
  • Richard K. Bear, Chief Financial Officer (Age 48)
  • Jay Kreger, President of CRH Anesthesia Management
  • David Johnson, Independent Director
  • Bergein F. Overholt M.D., Independent Director
  • Todd R. Patrick, Independent Director (Age 48)
  • Ian A. Webb, Independent Director (Age 61)

Who owns CRH Medical stock?

CRH Medical's stock is owned by a number of of retail and institutional investors. Top institutional investors include Mawer Investment Management Ltd. (8.05%), Stifel Financial Corp (2.25%), Canada Pension Plan Investment Board (0.00%), JPMorgan Chase & Co. (0.55%), TD Asset Management Inc. (0.15%) and AGF Investments Inc. (0.11%). View Institutional Ownership Trends for CRH Medical.

Who sold CRH Medical stock? Who is selling CRH Medical stock?

CRH Medical's stock was sold by a variety of institutional investors in the last quarter, including AGF Investments Inc.. View Insider Buying and Selling for CRH Medical.

Who bought CRH Medical stock? Who is buying CRH Medical stock?

CRH Medical's stock was bought by a variety of institutional investors in the last quarter, including Mawer Investment Management Ltd., Canada Pension Plan Investment Board, JPMorgan Chase & Co., Stifel Financial Corp and TD Asset Management Inc.. View Insider Buying and Selling for CRH Medical.

How do I buy CRH Medical stock?

Shares of CRH Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CRH Medical's stock price today?

One share of CRH Medical stock can currently be purchased for approximately $1.80.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of $140.84 million.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.


MarketBeat Community Rating for CRH Medical (NYSEAMERICAN CRHM)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  65 (Vote Underperform)
Total Votes:  148
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for CRH Medical (NYSEAMERICAN:CRHM)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 3 Hold Ratings, 6 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $7.83

Consensus Price Target History for CRH Medical (NYSEAMERICAN:CRHM)

Price Target History for CRH Medical (NYSEAMERICAN:CRHM)

Analysts' Ratings History for CRH Medical (NYSEAMERICAN:CRHM)

Show:
DateFirmActionRatingPrice TargetDetails
11/17/2017Morgan StanleyUpgradeEqual Weight -> OverweightView Rating Details
8/4/2017Canaccord GenuityLower Price TargetBuy$8.00 -> $5.00View Rating Details
8/4/2017National Bank FinancialUpgradeSector Perform -> OutperformView Rating Details
7/24/2017ScotiabankUpgradeSector Perform -> Sector OutperformView Rating Details
7/21/2017Royal Bank Of CanadaUpgradeSector Perform -> OutperformView Rating Details
7/18/2017TD SecuritiesDowngradeBuy -> HoldView Rating Details
7/14/2017Bloom BurtonDowngradeBuy -> AccumulateView Rating Details
7/17/2017CIBCDowngradeSector Outperform -> Sector PerformView Rating Details
3/27/2017Cantor FitzgeraldReiterated RatingOverweight$8.00 -> $10.00View Rating Details
(Data available from 11/22/2015 forward)

Earnings

Earnings History and Estimates Chart for CRH Medical (NYSEAMERICAN:CRHM)

Earnings by Quarter for CRH Medical (NYSEAMERICAN:CRHM)

Earnings History by Quarter for CRH Medical (NYSEAMERICAN CRHM)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018        
2/22/201712/31/2016$0.04$0.05$23.30 million$25.82 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CRH Medical (NYSEAMERICAN:CRHM)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for CRH Medical (NYSEAMERICAN:CRHM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CRH Medical (NYSEAMERICAN CRHM)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for CRH Medical (NYSEAMERICAN CRHM)

Source:
DateHeadline
CRH Medical Co. (CRHM) Raised to Weight at Morgan StanleyCRH Medical Co. (CRHM) Raised to Weight at Morgan Stanley
www.americanbankingnews.com - November 17 at 10:58 AM
CRH Medical Co. (CRHM) Receives Average Recommendation of "Hold" from AnalystsCRH Medical Co. (CRHM) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 16 at 8:00 AM

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

CRH Medical (NYSEAMERICAN CRHM) Chart for Wednesday, November, 22, 2017
Loading chart…

This page was last updated on 11/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.